Construction and application of a yeast expression system for thymosin alpha1. 2005

Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
Institute of Infectious Diseases, 1st Affiliated Hospital, Medical College of Zhejiang University, Key Lab. of Infectious Diseases, Ministry of Public Health, Hangzhou, 310003 China. xinlanchen222@hotmail.com

We want to construct a yeast expression system for thymosin alpha1 (Talpha1) to make the orally administered Talpha1 preparation possible. The whole Talpha1 DNA fragment was obtained by PCR. After being digested with restriction enzymes, it was cloned into pYES2 vector. Sequencing was performed to identify the recombinant. The sequence of Talpha1 in recombinant coincided with the original one reported in Genbank. When pYES2-Talpha1 plasmid was transformed into yeast, galactose instead of glucose was used to induce Talpha1 expression. Western blot was performed to identify the quality of the expressed Talpha1. Dried yeast containing pYEST2-Talpha1 was fed to Balb/c mice whose immunities were inhibited by cyclophosphamide in advance. Synthesized Talpha1 peptide was used as positive control and empty yeast was used as negative control. Compared with the negative control group, both dried yeast containing pYEST2-Talpha1 and synthesized Talpha1 peptide can significantly increase the CD8+ level (22.74 +/- 1.09 and 18.77 +/- 4.72 vs 7.49 +/- 2.14, p < 0.01), while both of them had little effect on the CD4+ lymphocytes (61.86 +/- 6.94 and 65.91 +/- 4.78 vs 57.93 +/- 10.40,p > 0.05). We concluded that a high effective yeast expression system for Talpha1 was constructed successfully and the Talpha1 protein expressed by this system can improve CD8+ level in immune inhibited mice.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations

Related Publications

Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
February 2005, Biotechnology letters,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
November 2002, Yi chuan = Hereditas,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
January 2004, Bioorganicheskaia khimiia,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
July 2008, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
September 2007, Annals of the New York Academy of Sciences,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
May 2002, Current opinion in investigational drugs (London, England : 2000),
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
June 2013, Molecular biotechnology,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
September 2017, FEMS yeast research,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
January 2009, Medicinski arhiv,
Feng Chen, and Xiang-Ming Chen, and Zhi Chen, and Han-Liang Jiang, and Xiao-Ping Pan, and Zhong-Rong Hu, and Rong-Hua Liu, and Xiao-Ming Chen
May 2011, Protein expression and purification,
Copied contents to your clipboard!